vaginal cancer (Cancer)
Information
- Disease name
- vaginal cancer
- Disease ID
- DOID:119
- Description
- "A female reproductive system cancer that is located_in the vagina." [url:http\://www.cancer.gov/dictionary?CdrID=523460]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT02653118 | Active, not recruiting | Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) | January 22, 2016 | January 1, 2040 | |
NCT00002949 | Completed | Phase 1 | Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis | July 1996 | May 2001 |
NCT03158220 | Completed | Phase 3 | Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004) | September 20, 2017 | November 19, 2018 |
NCT03346915 | Completed | N/A | Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention | August 14, 2018 | April 19, 2019 |
NCT00005941 | Completed | Phase 2 | Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer | November 1999 | June 2005 |
NCT00033605 | Completed | Phase 3 | Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | April 2002 | July 2006 |
NCT00002562 | Completed | Phase 2 | Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer | March 1994 | August 2004 |
NCT00275353 | Completed | Phase 2 | Effectiveness of an Individualized Symptom Education Program (ISEP) | July 2003 | February 2006 |
NCT00287885 | Completed | Phase 1 | Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer | March 2004 | December 2008 |
NCT00381888 | Completed | Phase 2 | Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer | January 2007 | January 2009 |
NCT00520598 | Completed | Phase 2 | Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) | October 2007 | May 2011 |
NCT00528034 | Completed | N/A | Lymphoscintigraphy in Patients With Vaginal Cancer | September 2002 | May 2008 |
NCT00543543 | Completed | Phase 3 | Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) | September 24, 2007 | July 7, 2016 |
NCT00545792 | Completed | Phase 2 | Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers | May 2007 | October 2013 |
NCT00551187 | Completed | Phase 2 | A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) | October 2007 | May 2009 |
NCT00578006 | Completed | N/A | Internet-based System for Cancer Patients to Self-report Toxicity | March 2004 | January 2017 |
NCT00581646 | Completed | Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance | September 2006 | June 2015 | |
NCT00588081 | Completed | N/A | Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function | May 2001 | August 2016 |
NCT00003267 | Completed | Phase 3 | Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer | February 1998 | |
NCT02280811 | Completed | Phase 1/Phase 2 | T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers | October 14, 2014 | June 28, 2016 |
NCT03676101 | Completed | Phase 1 | Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | October 10, 2018 | January 10, 2020 |
NCT05372016 | Completed | Phase 3 | Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | September 19, 2020 | June 17, 2022 |
NCT00842452 | Completed | Phase 1 | Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery | February 2009 | April 2011 |
NCT00851643 | Completed | Phase 1 | Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002) | April 2006 | November 2009 |
NCT00870233 | Completed | Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life | March 24, 2009 | February 12, 2018 | |
NCT04626466 | Completed | Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation | August 3, 2020 | January 2, 2024 | |
NCT00943722 | Completed | Phase 3 | A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) | August 27, 2009 | April 22, 2021 |
NCT00944944 | Completed | Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema | July 2009 | January 2010 | |
NCT04425291 | Completed | Phase 3 | Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | May 28, 2020 | September 6, 2021 |
NCT03956498 | Completed | N/A | Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by Radiotherapy and Brachytherapy | October 9, 2019 | February 20, 2022 |
NCT01216813 | Completed | Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer | August 2010 | December 2010 | |
NCT01399658 | Completed | Phase 2 | Image-Guided Gynecologic Brachytherapy | September 2011 | June 2016 |
NCT01582906 | Completed | A Survivorship Care Plan for Gynaecological Cancer Patients | August 2011 | April 2015 | |
NCT01585428 | Completed | Phase 2 | Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers | April 13, 2012 | August 1, 2016 |
NCT01703195 | Completed | N/A | Magnetic Resonance Imaging of Gynecologic Malignancies Involving the Vagina | November 2012 | September 19, 2019 |
NCT01851928 | Completed | Validation of a Nutrition Screening Tool | July 2011 | March 2013 | |
NCT02714621 | Completed | N/A | MR-HIFU for Recurrent Gynaecological Cancer | May 2016 | March 31, 2020 |
NCT02058550 | Completed | Phase 1 | Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy | September 2014 | October 23, 2020 |
NCT02096783 | Completed | N/A | Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer | September 2014 | June 2016 |
NCT05639972 | Not yet recruiting | Phase 1/Phase 2 | E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers | June 12, 2024 | October 1, 2026 |
NCT06284343 | Not yet recruiting | Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study | April 1, 2024 | September 30, 2026 | |
NCT06432478 | Recruiting | N/A | 3D Printed Custom Applicators for HDR BT (DISCO) | November 24, 2023 | September 2028 |
NCT00005095 | Recruiting | Specimen and Data Study for Ovarian Cancer Early Detection and Prevention | March 2000 | December 2040 | |
NCT02012699 | Recruiting | Integrated Cancer Repository for Cancer Research | November 1, 2013 | December 2099 | |
NCT02993900 | Recruiting | N/A | Image-Guided Gynecologic Brachytherapy | December 15, 2016 | December 2028 |
NCT05242861 | Recruiting | Retrospective Study of Brachytherapy | February 20, 2022 | December 31, 2027 | |
NCT05371353 | Recruiting | Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine | May 14, 2022 | May 2027 | |
NCT05561413 | Recruiting | N/A | Gynaecology Exercise and Mindfulness Study | June 14, 2022 | May 2023 |
NCT05686226 | Recruiting | Phase 2 | E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers | March 7, 2023 | January 1, 2025 |
NCT05743517 | Recruiting | N/A | Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) | September 15, 2023 | August 1, 2029 |
NCT05979610 | Recruiting | Phase 2 | Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies | October 9, 2023 | April 1, 2027 |
NCT06203106 | Recruiting | NYSCF Scientific Discovery Biobank | November 10, 2022 | November 10, 2045 | |
NCT06314568 | Recruiting | Radiochemotherapy and Interventional Radiotherapy in Vaginal Cancer | March 15, 2024 | December 31, 2028 | |
NCT06339827 | Recruiting | N/A | ASk Questions in GYnecologic Oncology (ASQ-GYO) | April 4, 2024 | May 2027 |
NCT04028479 | Recruiting | The Registry of Oncology Outcomes Associated With Testing and Treatment | May 5, 2021 | October 1, 2031 | |
NCT04278326 | Recruiting | N/A | Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments | March 6, 2020 | April 2024 |
NCT04422366 | Recruiting | Phase 3 | Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | April 28, 2020 | September 15, 2029 |
NCT04708470 | Recruiting | Phase 1/Phase 2 | A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers | October 5, 2021 | December 31, 2025 |
NCT04895020 | Recruiting | Phase 3 | Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years | May 28, 2021 | May 2026 |
NCT04977453 | Recruiting | Phase 1/Phase 2 | GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors | August 2, 2021 | October 2026 |
NCT05027776 | Recruiting | Phase 3 | Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years | September 15, 2021 | September 29, 2026 |
NCT00669422 | Terminated | ChemoFx® PRO - A Post-Market Data Collection Study | October 2006 | October 2012 | |
NCT02458001 | Unknown status | N/A | Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer | July 2015 | March 2017 |
NCT00601406 | Unknown status | N/A | Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | March 2006 | |
NCT03611517 | Unknown status | N/A | Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer | August 7, 2018 | July 2022 |
NCT00800644 | Unknown status | Pelvic Fractures and Radiation Therapy for Cervical Cancer | November 5, 2008 | November 30, 2020 | |
NCT01087268 | Unknown status | Phase 3 | Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer | January 2009 | |
NCT00905658 | Unknown status | Phase 2 | Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer | June 2008 | |
NCT00118300 | Withdrawn | Phase 1 | Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer | April 2005 | |
NCT01097239 | Withdrawn | Phase 1/Phase 2 | Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer | November 2009 | September 2018 |
- Disase is a (Disease Ontology)
- DOID:120
- Cross Reference ID (Disease Ontology)
- GARD:9348
- Cross Reference ID (Disease Ontology)
- ICD10CM:C52
- Cross Reference ID (Disease Ontology)
- ICD9CM:184.0
- Cross Reference ID (Disease Ontology)
- MESH:D014625
- Cross Reference ID (Disease Ontology)
- NCI:C3437
- Cross Reference ID (Disease Ontology)
- NCI:C7410
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:126921000
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:188210000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0042237
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0042258
- Exact Synonym (Disease Ontology)
- malignant neoplasm of vagina
- Exact Synonym (Disease Ontology)
- malignant tumor of vagina
- Exact Synonym (Disease Ontology)
- malignant vaginal tumor
- Exact Synonym (Disease Ontology)
- neoplasm of vagina
- Exact Synonym (Disease Ontology)
- vagina neoplasm
- Exact Synonym (Disease Ontology)
- vaginal tumor